# Pharmacokinetic Drug Interaction Between Pregabalin and Thioctic Acid.

> **NCT01808300** · PHASE1 · COMPLETED · sponsor: **Unimed Pharmaceuticals** · enrollment: 42 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Pregabalin 300mg, Thioctic acid 600mg

## Key facts

- **NCT ID:** NCT01808300
- **Lead sponsor:** Unimed Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2013-07
- **Final completion:** 2013-08
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2013-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01808300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01808300, "Pharmacokinetic Drug Interaction Between Pregabalin and Thioctic Acid.". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01808300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*